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Pancreatic carcinogenesis -enhancement by cholecystokinin
in the hamster-nitrosamine model
A.G. Howatson* & D.C. Carter
University Department ofSurgery, Royal Infirmary, Glasgow, Scotland, UK.
Summary The role of the pancreaticotrophic hormone cholecystokinin (CCK) in modifying the pancreatic
response to carcinogen has been examined in the hamster-nitrosamine pancreatic cancer model. Exogenous
CCK, 30IDUkg-1, stimulated a maximal pancreatic secretory response when given intravenously and caused
hypertrophy and hyperplasia of the pancreas when given subcutaneously over a period of 6 weeks (pancreatic
wet weight, mg per lOOg body weight, controls 295.6+61; CCK treated 466.4+77, P<0.001). When the
same dose of CCK was given to animals receiving N-nitrosobis (2-oxopropyl)amine (BOP; 5mgkg-1 weekly)
there was a reduction in latency period and increase in induction rate of tumour development (CCK+BOP
vs. BOP alone, 12 animals with tumours vs. 2 at 15 weeks; P<0.02). These effects are consistent with CCK
acting as a co-carcinogen or promoter ofpancreatic carcinogenesis in this model.
Although the aetiology of carcinoma of the
pancreas is unknown, epidemiological studies have
identified a number of associations which support
the concept that pancreatic cancer is the result of
chemical carcinogenesis (Wynder, 1975). Potential
carcinogens responsible for tumour development
could be present in tobacco smoke (Hoffmann et
al., 1974, 1975), food (Wynder, 1975) or particular
occupational environments (Mancuso & El-Altar,
1967; Li et al., 1969).
It has also been suggested that co-carcinogens or
promoters (either exogenous or endogenous) may
have an important role to play in enhancing the
carcinogenic process. Of particular interest is the
possibility that cholecystokinin, released from the
duodenal mucosa as a result of the ingestion of a
fat-protein rich diet, may by its pancreaticotrophic
action increase pancreatic susceptibility to
carcinogens. It is well recognised that increased cell
metabolic activity and cell turnover increases tissue
susceptibility to carcinogens (Rous & Kidd, 1941;
Ryser, 1971). This paper reports a series of
experiments to determine the potential of
cholecystokinin (CCK) to enhance pancreatic
carcinogenesis in the hamster-nitrosamine model
developed by Pour et al. (1977).
Materials and methods
The animals used in all studies were 10 weeks old
male Syrian hamsters kept under standardised
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conditions in groups of four and fed Oxoid 41B
diet and water ad libitum.
Effect ofCCK on pancreatic exocrine secretion
The effect of step-wise increasing doses of
exogenous cholecystokinin (20% natural CCK,
GIH Research Unit, Karolinska Institute) was
studied in twelve hamsters. The mean body weight
of the animals was 84.3 +8.5g.
After a 24h fast with free access to water the
animals were anaesthetized with intraperitoneal
"Sagatal" (May & Baker Ltd.). Tracheostomy was
performed and an intravenous cannula was inserted
into the left jugular vein. A saline infusion (0.9%)
at a rate of 0.375mlh-1 was commenced using a
syringe infusion pump (B. Braun Melsugen AG). A
laparotomy was performed through a midline
incision, the common bile duct ligated in continuity
just distal to the entry of the cystic duct, and the
pylorus ligated. The common bile duct was
cannulated in the wall of the duodenum to permit
collection of pancreatic juice (Portex Ltd., 2FG,
Outer diameter 0.63mm). The cannula was secured
by a suture and led out through the flank. The
body temperature was maintained at 34°C with a
heating pad.
An equilibration period of 1 h was allowed before
commencement of the test. Pancreatic juice was
collected in pre-weighed tubes placed below the
hamster. A basal output was collected for 1 h and
thereafter step-wise increasing doses of CCK in
saline were infused. Collections at each dose level
were made for 1 h, and 20min was allowed for
equilibration between doses. The volume output
was measured by weighing. At the end of each test
a lissamine green dye solution was injected up the
cannula. A test was regarded as technically
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satisfactory if the whole gland was stained
suggesting that all of the pancreas had been
draining into a patent duct system.
Trophic effect ofcholecystokinin
Two experiments were performed to examine the
effect of exogenous CCK on the hamster pancreas.
The dose of CCK used in these studies was selected
from the above dose response studies as that
producing a maximal response in terms of
pancreatic juice output when given intravenously.
In the first experiment two groups of 10 animals
(mean body weight CCK group 95.6±6.3g; control
group 88.4+7.2g) received either CCK
30IDUkg-1 twice daily by s.c. injection for 15
days in hydrolysed gelatin carrier or gelatin carrier
alone. The CCK was made up in 10% hydrolysed
gelatin in saline in order to prolong absorption
(Petersen et al., 1978).
In the second experiment, two groups of 10
animals (mean body weight CCK group
77.6+4.6g; control group 83.1 +7g) received either
CCK 30IDUkg 1 twice daily for 3 days per week
for 6 weeks in hydrolysed gelatin carrier, by s.c.
injection, or gelatin carrier alone.
At the end of each experiment the animals were
killed, the pancreas removed, trimmed of fat and
connective tissue and weighed. Tissue from two
sites in both the gastric and splenic lobes of the
pancreas was fixed in formalin and examined
histologically after staining with haematoxylin and
eosin and was assessed using the same criteria as in
the carcinogen experiment. In addition to recording
pancreatic wet weight (PWW: mg pancreas per
100g body weight), the pancreatic content of DNA
(Mug DNA per 100mg PWW) was also determined.
The DNA was extracted from the homogenised
pancreas by the method of Schmidt-Thanhauser as
modified by Munro & Fleck (1966) and measured
by the modified Burton method (Burton, 1956;
Giles & Myers, 1965).
Co-carcinogenic potential ofcholecystokinin
Two groups of 100 animals received N-nitrosobis
(2-oxopropyl)amine (BOP: Ash Stevens Inc.,
Detroit, USA) in a dose of 5mgkg-1 once weekly
for life by subcutaneous injection. One group (mean
body weight 87+4.5g) also received
cholecystokinin 30IDUkg-1 b.d. in hydrolysed
gelatin s.c. for 3 days per week for 6 weeks on the
day before, the day of, and the day after
carcinogen; the other group (mean body weight
86.3+7.5g) received only the gelatin vehicle. CCK
was administered for 6 weeks because this was the
earliest stage at which well developed premalignant
microscopic lesions had been identified in pilot
studies of the model. All animals were weighed at
least twice weekly during the duration of the study.
Twenty animals from each treatment group were
scheduled to be killed at 5, 7.5, 10, 12.5 and 15
weeks. A full post-mortem examination was
performed and all major organs were examined
macroscopically for the presence of neoplastic
lesions. The pancreas was fixed en bloc in 10%
formalin and the whole organ was blocked, there
being an average of 11 blocks from each pancreas.
Three sections were taken from each block for
examination by light microscopy after staining with
haematoxylin and eosin. Macroscopic tumour
nodules, where present, were excised from the main
pancreatic specimen at the time of post-mortem and
separately sectioned for histological confirmation.
Each pancreas was assessed for the presence of
the following histological appearances affecting
ducts or of ductular morphology; duct dysplasia,
duct carcinoma-in-situ, ductular proliferation
(tubular complexes) and acinar-ductular
transformation affecting an entire lobule, and
pancreatic adenocarcinoma. Malignant tumours
that were intralobular and those that were frankly
invasive, i.e. extending outside the boundaries of a
pancreatic lobule, have been classified together
under the single heading of adenocarcinoma.
If any of these ductal/ductular lesions were present
in a histological section it was recorded as present
for that pancreas. No formal attempt was made to
quantify the extent or frequency of the lesions in
the pancreas. For the purposes of the histological
assessment, duct dysplasia and carcinoma-in-situ
have been reported separately. These lesions
represent atypical duct hyperplasia of varying
degrees of severity. The presence of mitoses was a
pre-requisite for an atypical hyperplastic lesion with
nuclear pleomorphism and loss of epithelial
maturation to be regarded as carcinoma-in-situ
(Figure 1). The development of ductules, or tubular
complexes, both as a result of ductular cell
hyperplasia and acinar-ductular transformation was
regarded as a significant premalignant lesion if
virtually all of a lobule was involved in the process
(Figure 2). Intralobular carcinoma was defined as a
focus of carcinoma confined within the boundaries
of a pancreatic lobule. When the lobular boundary
was transgressed, the lesion was classified as frankly
invasive carcinoma (Figure 3). The progress
and development ofthese ductal/ductular and acinar
transformation lesions is outlined in Figure 4.
All sections were examined by a single observer
(AGH) and a proportion of slides (' 20%),
randomly selected by an individual not involved in
the series of experiments, were examined by a
trained pathologist who was not aware of the
nature and duration of the treatment given to any
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Figure 1 Pancreatic duct showing papilliform
overgrowth of the epithelium with pseudostratification,
pleomorphism, and mitotic activity. H&E x 360.
Figure 2 Pancreatic lobule showing ductular
proliferation and acinar-ductular transformation.
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Figure 3 Well differentiated pancreatic adeno-
carcinoma with a mild desmoplastic reaction.
H&E x 160.
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Figure 4 Histogenesis of pancreatic ductal and ductular lesions.
Statistical analysis
All data are expressed as mean + s.d. The analysis
of the dose response curve data was by Student's t-
test for paired observations. Student's t-test for
unpaired values was employed for the analysis of
the CCK trophism experiments, the data being
normally distributed. The analysis of the
histological assessment was by Fisher's exact test.
Results
Pancreatic exocrine secretion
Four of the twelve tests were excluded because of
incomplete staining of the pancreas by dye in three
cases and occlusion of the cannula by bile duct
mucosa in one case. The basal output of pancreatic
juice was 215.1 +175.Ulkg-1 h-1 (eight
observations) and rose sequentially to a maximum
of 515.0+125.5ylkg-'h-1 with infusion of CCK
at a dose of 30IDUkg-1h-' (P<0.01). The dose
response curve is shown in Figure 5.
Trophic effects ofcholecystokinin
Fifteen days of treatment with CCK resulted in the
development of a difference in mean pancreatic wet
weight (PWW) between control (236+27mg per
lOOg body weight) and treated animals
(532+72mg per I00g body weight; P<0.0O1). The
DNA content of the pancreatic tissue was also
increased from 93.2+ 17,ug per 100mg PWW
(control) to 137.3+16,ug per 100mg PWW (CCK)
(P<0.001).
Six weeks of treatment with CCK resulted in an
increase in pancreatic wet weight from 295.6+61 mg
per 100 g body weight (control) to 466.4 +77mg
per lOOg body weight (CCK) (P<0.001). The
DNA content of the pancreatic tissue was not
affected significantly (control 217.5+29.5/jIg per
100mg PWW: CCK 222.2+77.7,ug per 100mg
PWW).
Histological examination of sections from two
sites in both the gastric and splenic lobes of the
pancreas of animals receiving CCK for 6 weeks and
the corresponding controls was normal and in
particular showed no evidence of neoplastic lesions
in either group at 6 weeks. In the fifteen day and
six week experiments, the impression was gained
that the pancreatic acini contained more zymogen
granules and were larger in those animals receiving
CCK. No direct measurements of acinar size have
been made to support this impression but the effect
was not seen in pancreases at 7.5 and 10 weeks in
the carcinogen +CCK study.
Co-carcinogenic potential ofcholecystokinin
Sixty-three animals died before the appointed time
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W Pronlek.- lr%,Llfnl-ltlflmCHOLECYSTOKININ AND PANCREATIC CARCINOGENESIS 111
CCK IDU kg-1 h-1
Figure 5 Pancreatic juice volume response to increasing doses of CCK (mean ± s.d.: n =8).
of sacrifice as a result of infective enteritis unrelated
to carcinogen treatment. This condition is endemic
in hamsters and the causal organism is unknown.
No treatment is available and all animals
developing symptoms of diarrhoea and ascites died
within days. The prodromal phase could be
recognised by progressive weight loss for a few days
prior to the onset of diarrhoea. This feature proved
useful in identifying affected animals and permitted
their early isolation. Animals which did not develop
symptoms gained weight progressively during the
period of the study and appeared to be in good
health throughout.
No tumours were identified macroscopically in
any organs, other than the pancreas, at post-
mortem examination in either group. Metastatic
tumour was present in the lymph nodes draining
the gastric lobe of the pancreas of one CCK treated
animal with pancreatic lobular carcinoma of the
pancreas at 15 weeks.
Microscopic examination of the step sections of
animals sacrificed at 5 and 7.5 weeks showed no
adenocarcinomas and no significant difference
between the carcinogen alone and the carcinogen
+CCK groups in terms of the development of duct
dysplasia and lobular ductular proliferation. Forty
percent of animals in each group showed duct
dysplasia and 15% of the animals in the carcinogen
+CCK group showed duct carcinoma-in-situ at 7.5
weeks. No animals from either group showed
significant panlobular ductular proliferation at five
weeks, but by 7.5 weeks this was present in 15% of
the control group and 50% of the CCK treated
group.
The results of the histological assessments of the
groups at 10, 12.5 and 15 weeks are shown in
Tables I-III. At 10 weeks there was a significant
excess of duct carcinoma-in-situ and panlobular
ductular proliferation in the CCK treated group as
compared to the control group. There were no
adenocarcinomas in either group at 10 weeks. By
12.5 weeks more animals in the control (carcinogen
alone) group developed ductal lesions. A significant
difference between the two groups was seen with
respect to panlobular ductular proliferation and
adenocarcinomas which were more frequent in the
CCK treated group. At 15 weeks a significant
excess of adenocarcinomas, developing from
panlobular ductular proliferation was seen once
again in the CCK treated group. Premalignant and
Table I Effect of CCK on histological changes in
hamster pancreas induced by BOP at 10 weeks
BOP+CCK BOP
n=15 n= 10 P value
duct dysplasia 9 3 NS
duct carcinoma-in-situ 7 0 0.013
panlobular ductular
proliferation 9 1 0.016
pancreatic adenocarcinoma 0 0112 A.G. HOWATSON & D.C. CARTER
Table II Effect of CCK on histological changes in
hamster pancreas induced by BOP at 12.5 weeks
BOP+CCK BOP
n=17 n=13 P value
duct dysplasia 11 7 NS
duct carcinoma-in-situ 8 3 NS
panlobular ductular
proliferation 9 2 0.04
pancreatic adenocarcinoma 5 0 0.043
Table III Effect of CCK on histological changes in
hamster pancreas induced by BOP at 15 weeks
BOP+CCK BOP
n=17 n=10 P value
duct dysplasia 7 6 NS
duct carcinoma-in-situ 10 3 NS
panlobular ductular
proliferation 8 4 NS
pancreatic adenocarcinoma 12 2 0.015
malignant lesions developed earlier and with greater
frequency in the CCK treated group. There was full
agreement between the two histological assessors on
the presence of ductal and ductular lesions in 93%
of instances.
Discussion
N-nitrosobis (2-oxopropyl)amine, BOP, administered
by subcutaneous injection induces benign,
premalignant, and malignant lesions of ductal and
ductular morphology in the pancreas of Syrian
hamsters (Pour et al., 1977). The origin of these
lesions is the source of some controversy but it
appears from the present study that the neoplastic
cells arise from both ductal/ductular cells as
suggested by Pour (1978) and by the
transformation of acinar cells to cells of ductular
morphology as reported by Scarpelli & Rao (1978).
This model is widely considered to approximate
most closely to the morphology and biology of
human pancreatic cancer. The tumours are of
ductular morphology, the predominant pattern of
pancreatic cancer in man (Cubilla & Fitzgerald,
1980), and will invade locally, obstruct the common
bile duct causing jaundice, and metastasize to
lymph nodes, liver and other sites (Pour et al.,
1977).
The effects of co-carcinogens or promoters on
normal tissues and on cell populations exposed to
carcinogens are well known. Increased cell
metabolism, DNA synthesis, and mitotic activity, as
evidenced by tissue hypertrophy and hyperplasia,
are the common sequelae of exposure of normal
tissue to such agents. The responses of an initiated
cell population are a reduction in latency period
and an increased induction rate of tumour
development. Our studies on the co-carcinogenic
potential of CCK have examined whether these
changes occur in normal pancreas and in the
hamster-nitrosamine pancreatic cancer model.
The pancreatic secretory tests with
cholecystokinin showed a maximal effect on the
output of pancreatic juice with an i.v. dose of
30IDUkg-1 h-1. The reduced output at
60IDUkg- h-1 is attributable to depletion of
exocrine cell resources which is well recognised in
studies of this kind (Petersen et al., 1978).
The trophism experiments confirm_the capacity
of CCK to increase the cell metabolism and mitotic
rate of the cells of the exocrine pancreas as has
been noted previously (Petersen et al., 1978). The
fifteen day experiment with twice daily injections
showed induction of significant hypertrophy and
hyperplasia of the pancreas with a dramatic
increase in pancreatic wet weight and DNA
content. Giving CCK for three days per week for
six weeks induced significant hypertrophy as
evidenced by the increased pancreatic wet weight.
The DNA content per unit mass of pancreas was
not significantly increased by six weeks of CCK,
but the fact that the DNA content per unit mass
did not fall in the presence of an increase in
pancreatic wet weight shows that DNA synthesis
had occurred.
The difference in the DNA content of pancreatic
tissue in unstimulated animals in these two
experiments (93.2+17pg per 100mg PWW and
217.5+29.5jg per 100mg PWW) is the result of
the different periods of incubation during the
diphenylamine reaction used to measure the DNA
content of the pancreatic tissue. In the fifteen day
experiment the incubation time was six hours and
in the six week experiment it was fifteen hours. This
longer period permitted a greater degree of colour
development and thus a greater increase of DNA
content. This difference in no way invalidates the
results or alters the conclusions drawn on the
hyperplastic stimulus of CCK treatment as in both
cases the parallel CCK treated animals were dealt
with simultaneously and identically. Absolute
values of DNA content were of less importance
than the identification of a difference between the
groups, in any one experiment, after chole-
cystokinin treatment.
The suggestion of increased acinar size and
zymogen granule content in the pancreases of CCK
treated animals would be consistent with the
changes in pancreatic wet weight. The effects ofCHOLECYSTOKININ AND PANCREATIC CARCINOGENESIS 113
CCK would appear to be reversible quite rapidly
after 6 weeks of thrice weekly b.d. injections
because there was nothing to suggest a similar
appearance at 7.5 weeks in the carcinogen +CCK
study.
The trophism results provide evidence, in normal
tissue, that CCK induces changes similar to co-
carcinogens in other models and may therefore
have co-carcinogenic potential. However, while co-
carcinogens or promoters virtually always cause
hyperplasia, a hyperplastic stimulant need not
always be an effective promoter of carcinogenesis.
The determining factor is the effect on the latency
period and induction rate of tumour development.
The carcinogen experiment confirms the
carcinogenic effect of BOP on the hamster
pancreas. Addition of CCK resulted in significant
potentiation of the effect of BOP. Ductal lesions,
dysplasia and carcinoma-in-situ appeared earlier
and with greater frequency in the CCK treated
animals as compared to the controls exposed to
carcinogen alone. The effect of the carcinogen on
ductular and acinar cells in inducing acinar-
ductular transformation and ductular proliferation
with the subsequent development of lobular and
invasive adenocarcinoma is more dramatic.
Panlobular ductular proliferation, the premalignant
lesion which leads on to the development of
pancreatic lobular carcinoma, appeared in 60% of
the CCK group and only 10% of the control group
at 10 weeks. It is not until 15 weeks that the
percentage of animals in the control group showing
this lesion reached 40%. The absence of a
significant difference in panlobular ductular
proliferation between the BOP+CCK and BOP
alone groups at 15 weeks probably reflects the fact
that in the majority of animals, in the CCK group,
the lobular lesions had progressed to
adenocarcinoma. In the 12 of 17 animals with
adenocarcinoma the lesions were present in several
lobules in the majority. This implies that the
interval between sampling was such that the
premalignant phase was missed in most cases
because of the rapid progress of the neoplastic
process in this group as compared to the controls.
In the case of pancreatic lobular carcinoma and
invasive carcinoma the lesions appeared earlier in
the CCK treated group than in the carcinogen-
alone controls. The reduction in latency period and
increased induction rate of tumour development is
consistent with cholecystokinin serving as a co-
carcinogen or promoter.
CCK is trophic to both acinar and ductular cells
but it is generally accepted that its principal
function is to serve as a hormone trophic to acinar
cells.. The capacity of CCK to enhance carcino-
genesis as described above may be mediated simply
through the generation of increased numbers of
susceptible cells and intracellular targets for
carcinogen as a result of increased cell metabolism
and proliferation. However, a more interesting and
appealing concept is that CCK might influence the
metabolism of carcinogen.
N-nitrosobis (2-oxopropyl)amine is an indirect
carcinogen, as are all the nitrosamines, and must be
metabolised to produce carcinogenic forms. It is
now accepted that nitrosamines are metabolised by
mixed function oxidase (MFO) enzyme systems of a
number of tissues. The organ specificity of a given
carcinogen may well depend on the capacity of a
given tissue to metabolise the carcinogen. This
metabolism, in situ, of the indirect carcinogen or a
more proximate form transported to the target
organ after metabolism elsewhere, liver for
example, may be critical because of the very short
lived nature of the electrophilic radicals which are
generated in the final steps of the carcinogenic
processes (Miller, 1970). Early studies of
nitrosamine metabolism focussed on hepatic MFO
enzymes but more recently it has been clearly
shown that the pancreas, among other tissues, also
contains MFO enzymes which can metabolise
carcinogenic nitrosamines and generate mutagenic
metabolites as demonstrated by the Ames assay
(Scarpelli et al., 1980).
Studies with the tritium labelled carcinogenic
nitrosamine N-nitroso-2,6,di-methylmorpholine,
have shown that both acinar and ductal cells can
metabolise nitrosamines. The acinar cell population
appear to be the major site of metabolic activation
(Reznik-Schuller et al., 1980). Scarpelli et al. (1980)
have shown in vitro, that pancreatic MFO enzymes
are inducible and that the induction of these
enzymes is associated with an increase in the
conversion of carcinogens to mutagens. In vitro
studies have shown that the alkylation of guanine
at the 0-6 position, by electrophilic radicals derived
from nitrosamine, causes mutagenesis (Gerchman &
Ludlum, 1973; Margison et al., 1976). The trophic
effect of CCK on the pancreas as demonstrated in
this paper might include stimulation of those MFO
enzymes capable of nitrosamine metabolism. An
increase in metabolism of the carcinogen with
greater production of electrophilic radicals could
enhance the mutagenic effect by increasing
alkylation of DNA.
The present series of experiments may have
important implications for our understanding of the
pathogenesis of pancreatic cancer in hamsters and
other species including man. We have demonstrated
that exposure of the pancreas to a hormone,
normally released from the duodenum by the
ingestion of fat and protein, that acts as a stimulant
of pancreatic exocrine activity, potentiates the
action of carcinogen and/or increases pancreatic
susceptibility to carcinogen. The consumption of a114 A.G. HOWATSON & D.C. CARTER
fat-protein rich diet is associated with an increased
incidence of pancreatic cancer (Wynder, 1975;
Armstrong & Doll, 1975). Our studies suggest a
mechanism by which diet may affect pancreatic
carcinogenesis.
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